KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)

$12.16 -0.35 (-2.7978%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) News Sources

Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+

10-12-2025

yahoo.com

Kazia Therapeutics Regains Full Nasdaq Listing Compliance

22-12-2025

yahoo.com

US Equity Futures Mixed Pre-Bell Monday Despite Oil Sector Surge

05-01-2026

yahoo.com

Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End

08-01-2026

yahoo.com

Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

27-01-2026

yahoo.com

Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)

30-01-2026

yahoo.com

Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform

13-04-2026

yahoo.com

Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

15-04-2026

yahoo.com

How Kazia Therapeutics Ltd (KZIA) Is Strengthening Its Team and Platform

28-04-2026

yahoo.com

Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer

26-05-2026

yahoo.com

KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) Sentiment Trend

0 25 50 75 100 82 70 56 84 60 60 86 66 80 82 10-12-2025 22-12-2025 05-01-2026 08-01-2026 27-01-2026 30-01-2026 13-04-2026 15-04-2026 28-04-2026 26-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) FAQs

toggle

What is the current price of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)?

The current price of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) is $12.16.


toggle

KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) absolute price change since previous trading day?

The absolute price change of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) since the previous trading day is $-0.35.


toggle

KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) percentage price change since previous trading day?

The percentage price change of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) since the previous trading day is -2.7978%.


toggle

What is the most recent average sentiment score for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)?

The most recent average sentiment score for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) is 73 out of 100.


toggle

What is the most recent average sentiment for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)?

The most recent sentiment for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) is .


SEC-8K** Filing Available For KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.